L-arginine, the precursor of nitric oxide, abolishes the effect of estrogens on bleeding time in experimental uremia.
N. Perico , D. Corna , M. Noris , G. Vigano
Laboratory Investigation 65 ( 4) 479 -483
27
1991
Genetics of hemolytic uremic syndrome
M. Noris
Universiteit Maastricht
2006
The Toll-IL-1R Member Tir8 Modulates Post-Transplant Kidney Ischemia/reperfusion Injury By Inhibiting Resident F4/80+CX3CR1+ Cell Expansion.: Abstract# 2126
P. Cassis , S. Solini , N. Azzollini , G. Remuzzi
Transplantation 98 38
2014
PAF mediates neutrophil adhesion to thrombin or TNF-stimulated endothelial cells under shear stress.
D. Macconi , M. Foppolo , S. Paris , M. Noris
American Journal of Physiology-cell Physiology 269 ( 1)
45
1995
A young girl with MPGN/HUS and a heterozygous CFH-mutation
E. Bresin , C. Mossali , J. Caprioli , S. Rota
Molecular Immunology 44 ( 16) 3970
2007
Genetic analysis of the complement factor H related 5 gene in haemolytic uraemic syndrome
G. Monteferrante , S. Brioschi , J. Caprioli , G. Pianetti
Molecular Immunology 44 ( 7) 1704 -1708
37
2007
Erythropoietin enhances immunostimulatory properties of immature dendritic cells.
F. Rocchetta , S. Solini , M. Mister , C. Mele
Clinical and Experimental Immunology 165 ( 2) 202 -210
24
2011
Mutations of factor H (HF) in familial Hemolytic Uremic Syndrome (HUS) / Thrombotic Thrombocytopenic Purpura (TTP)
J. Caprioli , P. Bettinaglio , P.F. Zipfel , B. Vasile
Immunopharmacology 49 13
2
2000
ADAMTS13 Predicts Renal and Cardiovascular Events in Type 2 Diabetic Patients and Response to Therapy
E. Rurali , M. Noris , A. Chianca , R. Donadelli
Diabetes 62 ( 10) 3599 -3609
20
2013
Thrombotic microangiopathy without renal involvement: two novel mutations in complement-regulator genes.
F. Peyvandi , R. Rossio , B. Ferrari , L. A. Lotta
Journal of Thrombosis and Haemostasis 14 ( 2) 340 -345
2
2016
Role of thymic- and graft-dependent mechanisms in tolerance induction to rat kidney transplant by donor PBMC infusion.
R.A. Cavinato , F. Casiraghi , N. Azzollini , M. Mister
Kidney International 71 ( 11) 1132 -1141
3
2007
Mutations in FN1 cause glomerulopathy with fibronectin deposits
F. Castelletti , R. Donadelli , F. Banterla , F. Hildebrandt
Proceedings of the National Academy of Sciences of the United States of America 105 ( 7) 2538 -2543
81
2008
Localization of mesenchymal stromal cells dictates their immune or proinflammatory effects in kidney transplantation.
F. Casiraghi , N. Azzollini , M. Todeschini , R. A. Cavinato
American Journal of Transplantation 12 ( 9) 2373 -2383
128
2012
Thrombotic Microangiopathy After Kidney Transplantation
M. Noris , G. Remuzzi
American Journal of Transplantation 10 ( 7) 1517 -1523
145
2010
Structure-Function-Disease map for the genetic abnormalities in the central complement component C3
LT Roumenina , L Halbwachs-Mecarelli , P Bordereau , T Rybkine
Molecular Immunology 48 ( 14) 1674
2011
In patients with atypical hemolytic uremic syndrome C5 activation causes loss of endothelial thromboresistance
M. Galbusera , S. Gastoldi , F. Banterla , P. Macor
Molecular Immunology 48 ( 14) 1680
1
2011
Complement factor H (CFH) haploinsufficiency causes spontaneous late onset glomerulonephritis
M. Noris , N. Azzollini , M. Abbate , R. Donadelli
Molecular Immunology 48 ( 14) 1723
2011
Prevalence of C3 mutations in primary membranoproliferative glomerulonephritis
E. Valoti , E. Bresin , R. Piras , M. Alberti
Molecular Immunology 56 ( 3) 255
1
2013
Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature
L. Manenti , E. Gnappi , A. Vaglio , L. Allegri
Nephrology Dialysis Transplantation 28 ( 9) 2246 -2259
42
2013
Translational Mini‐Review Series on Complement Factor H: Therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis
M. Noris , G. Remuzzi
Clinical and Experimental Immunology 151 ( 2) 199 -209
23
2008